IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules (Business Wire via Yahoo! Finance)
HAYWARD, Calif.----IMPAX Laboratories, Inc. , through its generic drug division Global Pharmaceuticals, announced that yesterday the U.S. Food and Drug Administration granted final approval of the Company's Abbreviated New Drug Application for a generic version of Prilosec 40 mg Delayed-release Capsules.

Abbott Receives FDA CLIA Waiver For Use Of Five Additional Cartridges On The I-STAT Handheld Blood Analyzer (Medical News Today)
Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for five additional test cartridges used by its i-STAT handheld blood analyzer. Cartridges for E3+, EC4+ and 6+ aid the clinician in assessing a patient's metabolic state within a few minutes.